GlassScriptPhysician profile
Daric Alexander Mueller
NPI 1578113171
$45,214.13
in general payments reported to CMS, 2019-2025
40 companies · $9,693 in 2025
The $9,693 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,073 · 2022: $5,399 · 2023: $15K · 2024: $12K · 2025: $9,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Consulting Fee: $8,698 · Travel and Lodging: $5,548 · Honoraria: $2,300 · Education: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,783.57 |
| Consulting Fee | $8,697.50 |
| Travel and Lodging | $5,548.27 |
| Honoraria | $2,300.00 |
| Education | $412.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13,452.50 | 2021-2025 | Cosentyx |
| Amgen INC. | $4,550.71 | 2021-2025 | Otezla, Tavneos, Krystexxa |
| Horizon Therapeutics Plc | $4,433.77 | 2021-2023 | Krystexxa, Uplizna |
| Abbvie INC. | $3,737.42 | 2021-2025 | |
| Ucb, INC. | $3,577.58 | 2021-2025 | Cimzia, Bimzelx |
| Astrazeneca Pharmaceuticals LP | $3,453.28 | 2022-2025 | Saphnelo, Flumist Quadrivalent, Evusheld |
| Janssen Biotech, INC. | $2,860.44 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| E.R. Squibb & Sons, L.L.C. | $1,610.35 | 2021-2025 | Orencia |
| Glaxosmithkline, LLC. | $970.38 | 2021-2025 | Benlysta |
| Pfizer INC. | $938.59 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $858.98 | 2022-2025 | Purified Cortrophin Gel |
| Lilly USA, LLC | $749.97 | 2021-2025 | Taltz |
| Genzyme Corporation | $579.91 | 2021-2025 | |
| Sandoz INC. | $457.33 | 2023-2025 | Hyrimoz, Jubbonti |
| Organon LLC | $389.22 | 2022-2025 | Hadlima, Renflexis, Nexplanon |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daric Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.